These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 11840146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J, Castillejo JA, Jiménez A, Maldonado J, Torres A.
    Med Clin (Barc); 1999 Dec 11; 113(20):779-82. PubMed ID: 10680143
    [Abstract] [Full Text] [Related]

  • 3. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G, Hernandez A, Heyll A, Wolf HH, Wernet P.
    Cancer Detect Prev; 1996 Dec 11; 20(6):601-9. PubMed ID: 8939346
    [Abstract] [Full Text] [Related]

  • 4. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V, Zoccolante A, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Martinazzo G, Bernabei PA, Ferrini PR.
    Haematologica; 1996 Dec 11; 81(3):201-7. PubMed ID: 8767524
    [Abstract] [Full Text] [Related]

  • 5. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC.
    Hematol Cell Ther; 1998 Oct 11; 40(5):224-8. PubMed ID: 9844816
    [Abstract] [Full Text] [Related]

  • 6. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
    Espérou H, Boiron JM, Cayuela JM, Blanchet O, Kuentz M, Jouet JP, Milpied N, Cahn JY, Faucher C, Bourhis JH, Michallet M, Tanguy ML, Vernant JP, Gabert J, Bordigoni P, Ifrah N, Baruchel A, Dombret H, French Bone Marrow Transplantation.
    Bone Marrow Transplant; 2003 May 11; 31(10):909-18. PubMed ID: 12748668
    [Abstract] [Full Text] [Related]

  • 7. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar 11; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 8. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2001 Apr 11; 27(8):809-15. PubMed ID: 11477437
    [Abstract] [Full Text] [Related]

  • 9. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S, Kim YJ, Chung NG, Lim J, Lee DG, Kim HJ, Min CK, Lee JW, Min WS, Kim CC.
    Cancer; 2009 Feb 01; 115(3):561-70. PubMed ID: 19117346
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F, Kirkland MA, van Rhee FV, Chase A, Coulthard S, Bungey J, Goldman JM, Cross NC.
    Bone Marrow Transplant; 1996 Dec 01; 18(6):1147-52. PubMed ID: 8971386
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G, Montefusco V, Testoni N, Amabile M, Saglio G, Ottaviani E, Terragna C, Bonifazi F, Rosti G, Bandini G, Tura S.
    Haematologica; 2000 Jun 01; 85(6):653-8. PubMed ID: 10870124
    [Abstract] [Full Text] [Related]

  • 12. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S, Nakao S, Ueda M, Yamazaki H, Takahashi S, Asano S, Yabe H, Kato S, Imoto S, Maruta A, Yoshida T, Gondo H, Morishima Y, Kodera Y.
    Bone Marrow Transplant; 2000 Oct 01; 26(7):769-74. PubMed ID: 11042659
    [Abstract] [Full Text] [Related]

  • 13. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, Galinsky I, Parekkedon B, Ritz J, Antin JH, Stone RM, Soiffer RJ.
    Clin Cancer Res; 2004 Aug 01; 10(15):5065-71. PubMed ID: 15297408
    [Abstract] [Full Text] [Related]

  • 14. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G.
    Ann Hematol; 2006 Jun 01; 85(6):366-73. PubMed ID: 16523310
    [Abstract] [Full Text] [Related]

  • 15. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.
    Miyamura K, Barrett AJ, Kodera Y, Saito H.
    Bone Marrow Transplant; 1994 Aug 01; 14(2):201-9. PubMed ID: 7994233
    [Abstract] [Full Text] [Related]

  • 16. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation.
    Arnold R, Janssen JW, Heinze B, Bunjes D, Hertenstein B, Wiesneth M, Kubanek B, Heimpel H, Bartram CR.
    Leukemia; 1993 May 01; 7(5):747-51. PubMed ID: 8483329
    [Abstract] [Full Text] [Related]

  • 17. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
    Kim YJ, Kim DW, Lee S, Min CK, Goh HG, Kim SH, Lee JY, Kim YL, Kim HJ, Kim HJ, Lee JW, Kim TG, Min WS, Kim CC.
    Biol Blood Marrow Transplant; 2004 Oct 01; 10(10):718-25. PubMed ID: 15389438
    [Abstract] [Full Text] [Related]

  • 18. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH, Bordone J, Etchegoyen O, Napal J, Prates MV, Morales VH.
    Medicina (B Aires); 1999 Oct 01; 59(1):1-10. PubMed ID: 10349111
    [Abstract] [Full Text] [Related]

  • 19. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L, López O, Martino R, Brunet S, Bellido M, Rubiol E, Sierra J, Nomdedéu JF.
    Haematologica; 2000 Jul 01; 85(7):704-10. PubMed ID: 10897122
    [Abstract] [Full Text] [Related]

  • 20. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul 01; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.